10
Participants
Start Date
February 29, 2008
Primary Completion Date
December 31, 2008
Study Completion Date
February 28, 2009
MESENDO
"2 ml of the final cell mixture will be injected through the lumen of an intracoronary percutaneous balloon designed for angioplasty into the ishcemic vessel."
TCA Cellular Therapy, LLC, Covington
Lead Sponsor
TCA Cellular Therapy
INDUSTRY